John R. Ieni
Affiliations: | Eisai, Inc., Andover, MA, United States |
Area:
Alzheimer'sGoogle:
"John Ieni"Mean distance: 16.75 (cluster 7) | S | N | B | C | P |
Cross-listing: Alzheimer's Tree
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Nirogi R, Ieni J, Goyal VK, et al. (2022) Effect of masupirdine (SUVN-502) on cognition in patients with moderate Alzheimer's disease: A randomized, double-blind, phase 2, proof-of-concept study. Alzheimer's & Dementia (New York, N. Y.). 8: e12307 |
| Doody RS, Corey-Bloom J, Zhang R, et al. (2008) Safety and tolerability of donepezil at doses up to 20 mg/day: results from a pilot study in patients with Alzheimer's disease. Drugs & Aging. 25: 163-74 |
| Feldman H, Gauthier S, Hecker J, et al. (2005) Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial. International Journal of Geriatric Psychiatry. 20: 559-69 |
| Krishnan KR, Charles HC, Doraiswamy PM, et al. (2003) Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. The American Journal of Psychiatry. 160: 2003-11 |
| Geldmacher DS, Provenzano G, McRae T, et al. (2003) Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease. Journal of the American Geriatrics Society. 51: 937-44 |
| Tune L, Tiseo PJ, Ieni J, et al. (2003) Donepezil HCl (E2020) Maintains Functional Brain Activity in Patients With Alzheimer Disease: Results of a 24-Week, Double-Blind, Placebo-Controlled Study American Journal of Geriatric Psychiatry. 11: 169-177 |
| Feldman H, Gauthier S, Hecker J, et al. (2003) P.4.040 Donepezil has significant functional and behavioral benefits in patients with severe Alzheimer's disease European Neuropsychopharmacology. 13 |
| Wilkinson DG, Passmore AP, Bullock R, et al. (2002) A multinational, randomised, 12-week, comparative study of donepezil and rivastigmine in patients with mild to moderate Alzheimer's disease. International Journal of Clinical Practice. 56: 441-6 |
| Mohs RC, Doody RS, Morris JC, et al. (2001) A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients. Neurology. 57: 481-8 |
| Provenzano G, Duttagupta S, McRae T, et al. (2001) Ppn13: Delays In Nursing Home Placement For Patients With Alzheimer'S Disease Associated With Treatment With Donepezil May Have Health Care Cost-Saving Implications Value in Health. 4: 158 |